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INTRODUCTION:  Metastatic  tumors  of  the  pancreas  are  uncommon  and  rarely  detectable  clinically.  Metas-
tases to  the  pancreas  are  rare.  We  present  a  patient  with  pancreatic  metastases  from  a leiomyosarcoma
of  the  uterus  and  review  the  literature  about  the  clinical  features  of  pancreatic  metastasis  and  its  surgical
management.
PRESENTATION  OF CASE:  A 40-year-old  woman,  who  underwent  hysterectomy,  left oophorectomy,  omen-
tectomy  and  lymp  node  dissection  for leiomyosarcoma  of  the uterus.  At  the  follow  up, the  patient
complained  of non-speciﬁc  abdominal  discomfort.  Preoperative  diagnosis  were  pancreatic  pseudocyst,
cystadenoma  or  cystadenocarcinoma.  At  laparotomy,  a cystic  mass  was  found  in the  tail of  the  pancreas
which  was  invased  to the  transverse  colon  mesenterium  and  the  spleen.  Distal  pancreatectomy  with
splenectomy  and  transverse  colon  resection  was  performed.  Histologically,  the  tumor  was  evaluated  as
poorly differentiated  leiomyosarcoma.
DISCUSSION:  Metastatic  lesions  of the pancreas  are  uncommon  and  less  than  2% of all  pancreatic  malig-
nancies.  However  a  few  cases  of leiomyosarcoma  with  metastases  to the  pancreas  have  been  reported  in
the literature.  Before  deciding  that  the  lesion  in  the  pancreas  was metastasis,  primary  leiomyosarcoma
of  the pancreas  had  to  be ruled  out.  Histologically,  leiomyosarcoma  of the  pancreas  contains  interlacing
spindle  cells  with  varying  degrees  of atypia  and  pleomorphism.  The  surgical  approach  to the pancreatic
metastases  must  be aimed  complete  excision  of the  tumor  with  a  wide  negative  margin  of  clear  tissue
and  maximum  preservation  of  pancreatic  remnant  if possible.
CONCLUSION:  In the  absence  of  widespread  metastatic  disease,  aggressive  surgical  approach  with  negative
margins  must  be aimed.
©  2014  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Metastatic tumors of the pancreas are uncommon and rarely
etectable clinically. The reported incidence of these tumors
anges from 3% to 11% in autopsy series.1 Most patients with
ancreatic metastases have widespread disease. Isolated, poten-
ially resectable pancreatic metastases are detected infrequently.2
lthough surgical resection of metastatic lesions to the liver, brain
nd lungs improve survival and quality of life, the management
f pancreatic metastases has not been clearly deﬁned.2,3 Uter-
ne leiomyosarcoma is a rare and aggressive malignant neoplasm
f the myometrial smooth muscle cells. The most common sites
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of distant metastases from leiomyosarcoma are the lung, kidney
and liver. Metastases to the pancreas is rare.4,5 The resection of
pancreatic metastases was  uncommon in the past because of the
high mortality and morbidity rates of pancreatic surgery. How-
ever, in recent years an improvement on pancreatic surgery has
been clearly shown.6 We  present a patient with pancreatic metas-
tases from a leiomyosarcoma of the uterus and review the literature
about the clinical features of pancreatic metastasis and its surgical
management.
2. Presentation of case
A 40-year-old woman, who  underwent hysterectomy, left
oophorectomy, omentectomy and lymp node dissection for
leiomyosarcoma of the uterus in December, 2008 and treated later
with radiation therapy and chemotherapy. The patient received
adjuvant chemotherapy with 75 mg/m2 doxorubicin a day and
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
CASE  REPORT  –  OPEN  ACCESS
S. Ozturk et al. / International Journal of Surgery Case Reports 5 (2014) 350–353 351
F
y
1
r
e
t
a
o
v
m
w
g
d
o
t
(
F
a
hig. 1. Post-contrast T1-weighted MRI  image of distal pancreatic mass shown with
ellow arrow.
00 mg/m2 cisplatin a day and received external-beam radiothe-
apy to the whole pelvis about 28 days. She was well without
vidence of disease recurrence at follow-up to May, 2013. At this
ime, the patient complained of non-speciﬁc abdominal discomfort
nd physical examination revealed a small epigastric mass. Lab-
ratory values revealed a border-line anemia with a hemoglobin
alue of 11.1 gr/dl (12.2–16.2 gr/dl), hipoalbuminemia with a albu-
in value of 3.1 gr/dl (3.5–5.2 gr/dl) and an increase of CA-125
ith a value of 445 U/ml (2.6–24 U/ml). Abdominal ultrasono-
raphy showed a hypoecoic mass measuring 4 cm at the widest
iameter in the tail of the pancreas. CT scan and MRI  showed
nly the pancreatic mass with a 4 cm at the widest diameter in
he tail of the pancreas, with no evidence of additional lesions
Fig. 1). A diagnosis of the serous papillary cystadenoma of the
ig. 3. The microscopical images of specimen with immunohistochemical staining. (A) 
ctivity), (B) smooth muscle actin (tumor cells positively reacting with SMA), (C) pancyto
ematoxylin and eosin (tumor neighboring the pancreatic tissue).Fig. 2. The image of distal pancreatectomy and splenectomy specimen ((A) spleen
and (B) distal pancreatic mass).
pancreas was  made on ﬁne-needle aspiration of the lesion guided
by ultrasonography. The diameter of the lesion was increased
probably a cystic hemorrhage after biopsy with a 25 cm at the
widest diameter in the abdominal ultrasonography. Whole-body
18-ﬂuorodeoxyglucose PET conﬁrmed these ﬁndings, and surgery
was planned by a multidisciplinary team. Preoperative diagnosis
were pancreatic pseudocyst, cystadenoma or cystadenocarcinoma.
At laparotomy, a cystic mass was found in the tail of the pan-
creas which was  invased to the transverse colon mesenterium and
the spleen. We  performed a frozen section from the mass and it
was reported as benign intraoperatively. Distal pancreatectomy
with splenectomy and transverse colon resection was  performed.
Mean operation time was 210 min. Mean blood loss was  800 cc
Hematoxylin and Eosin (solid tumor consisting of plump round cells with mitotic
keratin (original pancreatic tissue entrapped by solid mesenchymal tumor) and (D)
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nd 3 unit of erythrocyte transfusion was performed intraopera-
ively. In recovery period, pancreatic leakage was occurred with a
00 cc ﬂow daily. The patient was discharged 7 days after surgery
nd the pancreatic leakage ﬁnished spontaneously with a 2 month
ime. Gross examination of the surgical specimen revealed a 25 cm
ass involving the tail of the pancreas which was partially cystic
n cut section (Fig. 2). Histologically, the tumor was evaluated as
oorly differentiated leiomyosarcoma. 11 mitototic ﬁgures per 50
igh power ﬁelds were identiﬁed. The tissue lining the cystic cav-
ty was composed of hemorrhagic areas. No necrotic areas were
dentiﬁed. Immunohistochemical staining demonstrated that the
umor cells were diffuse strong positive for smooth muscle actin,
ocally strong positive for desmin, positive for vimentin, negative
or chromogranin, focally weak positive for Pancytokeratin (PAN-
K) and S-100 (Fig. 3). Metastatic leiomyosarcoma was diagnosed
istologically. She was treated neither chemotherapy nor radiation
herapy. Six months postoperatively the patient is well without
igns of recurrence.
. Discussion
Metastatic lesions of the pancreas are uncommon and less than
% of all pancreatic malignancies.1,3 The most common sites of
he primary lesions were lung, kidney and gastrointestinal tract.
owever a few cases of leiomyosarcoma with metastases to the
ancreas have been reported in the literature. Primary sites of
eiomyosarcomas included the uterus, ovary, veins, spermatic cord,
ntestine, retroperitoneum and soft tissue.2 Most patients have
idespread disease on diagnosis of pancreatic metastases, whereas
solated metastases to the pancreas are rare.1 The symptoms of pan-
reatic metastases are frequently nonspeciﬁc and generally include
bstructive jaundice, pain and weight loss, which are very similar
o the symptoms of primary pancreatic cancer.1,7 However, pancre-
tic metastases are frequently asymptomatic and detected during
he follow-up.1 The preoperative differential diagnosis between
 metastatic lesion and a primary pancreatic neoplasm may  be
ery difﬁcult because of the similarity of signs and symptoms
or both primary and secondary tumors.2,3 Accurate preoperative
taging must be done to avoid major surgery in patients with
idespread disease and 18-FDG-PET has proven to be useful for
ccurate staging.2,3 CT scan is usually performed to evaluate the
xtent of disease. Abdominal CT scans have revealed solid, cystic
nd heterogeneous images.6,7 Ultrasonography-guided ﬁne-needle
spiration is helpful in the correct preoperative diagnosis, espe-
ially in patients with widespread disease.2 Before deciding that
he lesion in the pancreas was metastasis, primary leiomyosarcoma
f the pancreas had to be ruled out. However, primary leiomyosar-
oma of the pancreas is rare, and the differential diagnosis is very
ifﬁcult because of the similarity between two.4 Also metastasis
rom tissues other than the uterus had to be ruled out secondly.
o gastrointestinal tract, the soft tissues of the extremities and
etroperitoneum must be investigated.4 Histologically, leiomyosar-
oma of the pancreas contains interlacing spindle cells with varying
egrees of atypia and pleomorphism which was orginated from the
alls of pancreatic blood vessels and pancreatic ducts. There is a
trong relationship between number of mitoses per high-powered
eld and tumor aggressiveness. Other features like cellularity,
egree of atypism and presence or absence of myoﬁbrils have also
een suggested for malign potential.7 Neither radiation therapy
or chemotherapy seems to be effective for leiomyosarcoma of the
terus. Giuntoli et al. studying 208 patients with leiomyosarcoma
f the uterus and showed that adjuvant pelvic radiation therapy
id not improve survival signiﬁcantly. Omura et al. reported that
here is no signiﬁcant difference in the recurrence rate after adju-
ant doxyrubicin therapy.4 The surgical approach to the pancreatic
1
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metastases must be aimed complete excision of the tumor with a
wide negative margin of clear tissue and maximum preservation of
pancreatic remnant if possible.5,7 Surgical options include pancre-
aticoduodenectomy, distal pancreatectomy, segmental resection
and in some cases total pancreatectomy depends on the location
of the lesion in the pancreas.5 Reported experience is limited and
there is no established guideline regarding appropriate manage-
ment of such lesions. When metastatic spread islimited to the
pancreas, an aggressive surgery seems to increase survival and
quality of life.1,2 The presence of extrapancreatic disease together
with pancreatic metastases is not always a contraindication to
resection, if it is technically possible.6 The survival rate after surgery
is not clear and well-established because of the minority of cases
but the curative surgery with wide margins seemed to be the best
surgical option for these patients.1,2
4. Conclusion
In the absence of widespread metastatic disease, aggressive sur-
gical approach with negative margins must be aimed. Because it is
associated with improved long-term survival and is the only hope
for cure for these patients.1,6,7
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Key learning points
We  summarize the importance of R0 resection in pancreatic
leiomyosarcoma metastasis. Because it is the only curative hope for
these patients due to insufﬁcient response to radiochemotherapy
References. Falconi M,  Crippa S, Sargenti M,  Capelli P, Pederzoli P. Pancreatic metastasis
from leiomyosarcoma of the broad ligament of the uterus. Lancet Oncol 2006;7:
94–5.
. Koh YS, Kim JC, Cho CK, Kim HJ. Pancreatic metastasis of leiomyosarcoma in the
right thigh: a case report. World J Gastroenterol 2007;13(7):1135–7.
 –  O
 of Sur
3
4
5
6
O
T
p
cCASE  REPORT
S. Ozturk et al. / International Journal
. You DD, Choi DW,  Choi SH, et al. Surgical resection of metastasis to the pancreas.
J  Korean Surg Soc 2011;80:278–82.. Iwamoto I, Fujino T, Higashi Y, et al. Metastasis of uterine leiomyosarcoma to the
pancreas. J Obstet Gynaecol Res 2005;6:531–4.
. Gomez JA, Sanchez AA, Cecilia DM,  et al. Uterine leiomyosarcoma metastasis to
the pancreas: report of a case and review of the literature. J Gastrointest Cancer
2012;43(2):361–3.
7
pen Access
his article is published Open Access at sciencedirect.com. It is distrib
ermits unrestricted non commercial use, distribution, and reproduct
redited.PEN  ACCESS
gery Case Reports 5 (2014) 350–353 353
. Sperti C, Pasquali C, Liessi G, Pinciroli L, Decet G, Pedrazzoli S. Pancre-
atic resection for metastatic tumors to the pancreas. J Surg Oncol 2003;83:
161–6.
. Deveaux PG, Aranha GV, Yong S. Leiomyosarcoma of the pancreas. HPB
2001;3(2):175–7.
uted under the IJSCR Supplemental terms and conditions, which
ion in any medium, provided the original authors and source are
